Enzyme-entrapped mesoporous silica for treatment of uric acid disorders

Journal of Biomedical Nanotechnology

Volumn 9, Issue 5, 2013, Pages 907-914

  Muthukoori, Shanthini ^a   Narayanan, Naagarajan ^a   Chandra, Manuguri Sesha Sarath ^a   Sethuraman, Swaminathan ^a   Krishnan, Uma Maheswari ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Gout; Permeation Enhancer; SBA 15; Transdermal; Uricase

Indexed keywords

GOUT; PERMEATION ENHANCERS; SBA-15; TRANSDERMAL; URICASE;

MESOPOROUS MATERIALS; ORGANIC ACIDS; RATS;

ENZYME IMMOBILIZATION;

BORIC ACID; OLEIC ACID; PROPYLENE GLYCOL; SILICON DIOXIDE; URATE OXIDASE; URIC ACID;

ADSORPTION; ANIMAL TISSUE; ARTICLE; CADAVER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PENETRATION; DRUG RELEASE; ENZYME ACTIVITY; ENZYME IMMOBILIZATION; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SKIN PERMEABILITY; SYNTHESIS; TRANSDERMAL PATCH; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; ENZYME REPLACEMENT THERAPY; ENZYMES, IMMOBILIZED; GOUT; GOUT SUPPRESSANTS; HUMANS; MODELS, BIOLOGICAL; POROSITY; RATS; RATS, WISTAR; SILICON DIOXIDE; SKIN ABSORPTION; URATE OXIDASE; URIC ACID;

EID: 84877751184     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1588     Document Type: Article

References (29)

1. H. K. Choi, D. B. Mount, and A. M. Reginato, Pathogenesis of gout. Ann. Intern. Med. 143, 499 (2005).
2. T. R. Mikuls, J. T. Farrar, W. B. Bilker, S. Fernandes, H. R. Schumacher, Jr, and K. G. Saag, Gout epidemiology: Results from the UK general practice research database 1990-1999. Ann. Rheum. Dis. 64, 267 (2005).
3. R. C. Lawrence, D. T. Felson, C. G. Helmick, L. M. Arnold, H. K. Choi, R. A. Deyo, S. G. R. Hirsch, M. C. Hochberg, C. G. Hunder, J. M. Jordan, J. N. Katz, H. M. Kremers, and F. Wolfe, National arthritis data workgroup: Estimate of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum. 58, 26 (2008).
4. E. Roddy and M. Doherty, Gout epidemology of gout. Arthritis Res. Ther. 12, 223 (2010).
5. H. K. Choi, K. Atkinson, E. W. Karlson, and G. Curhan, Obesity, weight change, hypertension, diuretic use, and risk of gout in men: The health professionals follow up study. Arch. Intern. Med. 165, 742 (2005).
6. M. Segasothy, G. L. Chin, K. K. Sia, A. Zulfiqar, and S. A. Samad, Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Rheumatol. 34, 162 (1995).
7. K. Y. Kim, H. R. Schumacher, E. Hunche, D. Pol, A. I. Wertheimer, and S. X. Song, A literature review of the epidemiology and treatment of acute gout. Clin. Ther. 25, 1593 (2003).
8. G. Nuki, Gout. Med. 34, 417 (2005).
9. T. I. Evans, M. T. Wheeler, R. E. Small, S. A. Breitbach, K. M. Sanders, and W. N. Roberts, A comprehensive investigation of inpatient intravenous colchine use shows more education is needed. J. Rheumatol. 23, 143 (1996).
10. R. W. Kuncl, G. Duncan, D. Watson, K. Alderson, M. A. Rogawski, and M. Peper, Colchine myopathy and neuropathy. N. Engl. J. Med. 316, 1562 (1987).
11. X. Wu, M. D. Muzny, C. C. Lee, and C. T. Caskey, Two independent mutational events in the loss of urate oxidase during hominoid evolution. J. Mol. Evol. 34, 78 (1992).
12. L. N. Ramana, S. Sethuraman, U. Ranga, and U. M. Krishnan, Development of a liposomal nanodelivery system for nevirapine. J. Biomed. Sci. 17, 57 (2010).
13. H. Kalluri and A. K. Banga, Transdermal delivery of proteins. AAPS Pharma Sci. Tech. 12, 431 (2011).
14. H. Trommer and R. H. H. Neubert, Overcoming the stratum corneum, The modulation of skin penetration. Skin Pharmacol. Physiol. 19, 106 (2006).
15. S. Gandhi, S. Sethuraman, and U. M. Krishnan, Influence of polyhydric solvents on the catalytic and adsorption properties of self-oriented mesoporous SBA-15 silica. J. Mater. 18, 329 (2011).
16. S. Gandhi, S. Venkatesh, U. Sharma, N. R. Jagannathan, S. Sethuraman, and U. M. Krishnan, Super paramagnetic nanosystems based on iron oxide nanoparticles and mesoporous silica: Synthesis and evaluation of their magnetic, relaxometric and biocompatibility properties. J. Mater. Chem. 21, 15698 (2011).
17. S. Mirji, S. Halligudi, N. Mathew, N. Jacob, K. Patil, and A. Gaikwad, Adsorption of methanol on mesoporous SBA-15. Mater. Lett. 61, 88 (2009).
18. S. L. Brantley, Surface area and porosity of primary silicate minerals. Mineral. Magazine 62A, 229 (1998).
19. E. Girard, S. Marchal, J. Perez, S. Finet, R. Kahn, R. Fourme, G. Marassio, A. C. Dhaussy, T. Prange, M. Giffard, F. Dulin, F. Bonnete, R. Lange, J. H. Abraini, M. Mezouar, and N. Colloch, Structure-function perturbation and dissociation of tetrameric urate oxidase by high hydrostatic pressure. Biophysic. J. 98, 2365 (2010).
20. A. Nasir Vadia and S. Rajput, Mesoporous material, MCM-41: A new drug carrier. Asian J. Pharm. Clin. Res. 4, 44 (2011).
21. H. A. Benson, Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2, 23 (2005).
22. S. A. Mortazavi and R. Aboofazeli, An investigation into the effect of various penetration enhancers on percutaneous absorption of piroxicam. Iranian J. Pharm. Res. 2, 135 (2003).
23. B. M. Magnusson, K. A. Walters, and M. S. Roberts, Veterinary drug delivery: Potential for skin penetration enhancement. Adv. Drug Deliv. Rev. 50, 205 (2001).
24. Q. Y. Tana, N. Wang, H. Yang, K. L. Zhang, S. Liu, L. Chen, J. Liu, L. Zhang, N. N. Hu, C. J. Zhao, and J. Q. Zhang, Characterization, stabilization and activity of uricase loaded in lipid vesicles. Int. J. Pharm. 384, 165 (2010).
25. S. Andega, N. Kanikkannan, and M. Singh, Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control Release 77, 17 (2001).
26. S. Gao, Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int. J. Pharm. 165, 45 (1998).
27. A. Naik, L. A. R. M. Pechtold, R. O. Potts, and R. H. Guy, Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J. Control Release 37, 299 (1995).
28. H. J. Oh, Y. K. Oh, and C. K. Kim, Effects of vehicles and enhancers on transdermal delivery of melatonin. Int. J. Pharm. 212, 63 (2001).
29. K. Vávrová, K. Lorencová, J. Klimentová, J. Novotný, A. N. Holý, and A. Hrabálek, Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers. Eur. J. Pharm. Biopharm. 69, 597 (2008).